DARDAR Health Project (Disseminated Tuberculosis and HIV Infection)

Trial Profile

DARDAR Health Project (Disseminated Tuberculosis and HIV Infection)

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 22 Feb 2016

At a glance

  • Drugs IMM-201 (Primary)
  • Indications Tuberculosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms DARDAR
  • Most Recent Events

    • 16 Feb 2010 Pharmacodynamic substudy results presented at 17th Conference on Retroviruses and Opportunistic Infections.
    • 29 Jan 2010 Primary endpoint 'Occurrence of infection' has not been met.
    • 28 Jan 2010 Results have been published in AIDS.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top